Tuesday, May 10, 2016 10:38:43 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a)
Date : 05/09/2016 @ 4:40PM
Source : Edgar (US Regulatory)
Stock : Biorestorative Therapies, Inc. (QB) (BRTX)
Quote : 4.0 0.0 (0.00%) @ 8:08AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a)
Alert
UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.
FORM D
OMB APPROVAL
OMB Number: 3235-0076
Estimated Average burden hours per response: 4.0
Notice of Exempt Offering of Securities
1. Issuer's Identity
CIK (Filer ID Number) Previous Name(s) o None Entity Type
0001505497
Traxxec Inc.
Stem Cell Assurance, Inc.
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
BioRestorative Therapies, Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
x Over Five Years Ago
o Within Last Five Years (Specify Year)
o Yet to Be Formed
2. Principal Place of Business and Contact Information
Name of Issuer
BioRestorative Therapies, Inc.
Street Address 1 Street Address 2
40 Marcus Drive Suite One
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
Melville NEW YORK 11747 631-760-8100
3. Related Persons
Last Name First Name Middle Name
Weinreb Mark
Street Address 1 Street Address 2
c/o 40 Marcus Drive Suite One
City State/Province/Country ZIP/Postal Code
Melville NEW YORK 11747
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
Chief Executive Officer, Chairman of the Board and President
Last Name First Name Middle Name
Radov A. Jeffrey
Street Address 1 Street Address 2
8 Walworth Avenue
City State/Province/Country ZIP/Postal Code
Scarsdale NEW YORK 10583
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
Last Name First Name Middle Name
Clyde Mandy
Street Address 1 Street Address 2
c/o 40 Marcus Drive
Recent BRTX News
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:25:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:23:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:19:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:17:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:13:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:11:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:44:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 02:26:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 01:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:09:49 PM
- BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market • GlobeNewswire Inc. • 02/06/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:00:18 PM
- BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 02/05/2024 12:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM